BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 2996254)

  • 1. [Effect of TRH and its analog DN-1417 on anoxia-induced amnesia in mice].
    Yamazaki N; Shintani M; Saji Y; Nagawa Y
    Yakubutsu Seishin Kodo; 1985 May; 5(1):1-9. PubMed ID: 2996254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interaction with cholinergic drugs in reversal of cycloheximide-induced amnesia by thyrotropin-releasing hormone and its analog DN-1417 in mice].
    Yamazaki N; Shintani M; Saji Y; Nagawa Y
    Yakubutsu Seishin Kodo; 1983 Dec; 3(3):127-36. PubMed ID: 6431710
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological study of TA-0910, a new thyrotropin-releasing hormone (TRH) analog (IV): Effects on experimental memory impairment in mice and rats.
    Yamamura M; Kinoshita K; Nakagawa H; Ishida R
    Jpn J Pharmacol; 1991 Feb; 55(2):241-53. PubMed ID: 1906119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of sustained release formulation of thyrotropin-releasing hormone on learning impairments caused by scopolamine and AF64A in rodents.
    Miyamoto M; Hirai K; Takahashi H; Kato K; Nishiyama M; Okada H; Nagaoka A
    Eur J Pharmacol; 1993 Jul; 238(2-3):181-9. PubMed ID: 8405091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a new TRH analogue, YM-14673 on a passive avoidance test as a possible criterion of improvement in cognitive disturbance in rodents.
    Yamamoto M; Shimizu M
    Naunyn Schmiedebergs Arch Pharmacol; 1988 Sep; 338(3):262-7. PubMed ID: 3143078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NS-3 (CG3703), an analog of thyrotropin-releasing hormone, ameliorates cognitive impairment in rats.
    Ogasawara T; Ukai Y; Tamura M; Kimura K
    Pharmacol Biochem Behav; 1995 Apr; 50(4):499-503. PubMed ID: 7617693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pretraining administration of NC-1900, a vasopressin fragment analog, on memory performance in non- or CO2-amnesic mice.
    Sato T; Tanaka K; Teramoto T; Ohnishi Y; Hirate K; Irifune M; Nishikawa T
    Pharmacol Biochem Behav; 2004 Jun; 78(2):309-17. PubMed ID: 15219772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-6-ketopiperidine-2-carbonyl-L-leucyl-L-proline amide as a novel thyrotropin releasing hormone analogue with improving effects on impaired central nervous systems functions.
    Oka M; Ochi Y; Furukawa K; Ito T; Miura Y; Karasawa T; Kadokawa T
    Arzneimittelforschung; 1989 Mar; 39(3):297-303. PubMed ID: 2547386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary hormones and amnesia.
    Rigter H; Van Riezen H
    Curr Dev Psychopharmacol; 1979; 5():67-124. PubMed ID: 219989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of YM-14673, a new thyrotropin-releasing hormone analogue, on impaired learning of passive avoidance in mice.
    Yamamoto M; Ozawa Y; Takeuchi H
    Arch Int Pharmacodyn Ther; 1993; 321():5-13. PubMed ID: 8100705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of NC-1900, an active fragment analog of arginine vasopressin, and inhibitors of arachidonic acid metabolism on performance of a passive avoidance task in mice.
    Sato T; Ishida T; Irifune M; Tanaka K; Hirate K; Nakamura N; Nishikawa T
    Eur J Pharmacol; 2007 Mar; 560(1):36-41. PubMed ID: 17303115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of amnesia by an orally active ACTH 4-9 analog (Org 2766).
    Rigter H; Janssens-Elbertse R; Van Riezen H
    Pharmacol Biochem Behav; 1976; 5(Suppl 1):53-8. PubMed ID: 189332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of vasopressin analog: [d(CH2)(1)5,Tyr(Me)2,delta 3Pro7]AVP on learning and memory processes in rats with experimental amnesia.
    Car H; Borawska M; Wiśniewski K
    Pol J Pharmacol; 1993; 45(1):11-22. PubMed ID: 8401755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of lysine vasopressin on pentylenetetrazol-induced retrograde amnesia in rats.
    Bookin HB; Pfeifer WD
    Pharmacol Biochem Behav; 1977 Jul; 7(1):51-4. PubMed ID: 561964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effects of BY-1949 on three kinds of experimental amnesia in rodents].
    Tanabe S; Ikeda Y; Sugawa M; Iwasaki T
    Yakubutsu Seishin Kodo; 1990 Jun; 10(2):297-305. PubMed ID: 2251878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effect of idebenone (CV-2619) on cerebral ischemia-induced amnesia in rats.
    Yamazaki N; Take Y; Nagaoka A; Nagawa Y
    Jpn J Pharmacol; 1984 Nov; 36(3):349-56. PubMed ID: 6542947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of DN-1417 on ataxia in Rolling mouse Nagoya and Staggerer mouse in comparison with the effect of TRH].
    Matsui K; Mano Y; Ando K
    Yakubutsu Seishin Kodo; 1986 Jun; 6(2):281-3. PubMed ID: 3096012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of baclofen and L-AP4 in passive avoidance test in rats after hypoxia-induced amnesia.
    Car H; Wiśniewska RJ
    Pharmacol Rep; 2006; 58(1):91-100. PubMed ID: 16531635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of thyrotropin-releasing hormone (TRH) and its analog DN-1417 on scopolamine-induced impairment of short-term memory in rats].
    Yamazaki N; Nagaoka A; Nagawa Y
    Yakubutsu Seishin Kodo; 1986 Sep; 6(3):359-66. PubMed ID: 3101313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of VA-045 on learning and memory deficits in traumatic brain injury (TBI)-induced retrograde and anterograde amnesic mice.
    Tang YP; Noda Y; Hasegawa T; Nabeshima T
    Br J Pharmacol; 1997 Sep; 122(2):257-64. PubMed ID: 9313933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.